These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 33584245)

  • 21. Are Th17 cells and their cytokines a therapeutic target in Guillain-Barré syndrome?
    Wu X; Wang J; Liu K; Zhu J; Zhang HL
    Expert Opin Ther Targets; 2016; 20(2):209-22. PubMed ID: 26357850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The presence of Mycoplasma pneumoniae infection and GM1 ganglioside antibodies in Guillain-Barré syndrome.
    Sharma MB; Chaudhry R; Tabassum I; Ahmed NH; Sahu JK; Dhawan B; Kalra V
    J Infect Dev Ctries; 2011 Jul; 5(6):459-64. PubMed ID: 21727645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immune-mediated neuropathy and anti-glycolipid antibodies].
    Kaida K; Kusunoki S
    Brain Nerve; 2013 Apr; 65(4):413-23. PubMed ID: 23568989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guillain-Barré syndrome: epidemiology, pathophysiology and management.
    Kuwabara S
    Drugs; 2004; 64(6):597-610. PubMed ID: 15018590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guillain-Barré syndrome: a century of progress.
    Goodfellow JA; Willison HJ
    Nat Rev Neurol; 2016 Dec; 12(12):723-731. PubMed ID: 27857121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomarkers of Guillain-Barré Syndrome: Some Recent Progress, More Still to Be Explored.
    Wang Y; Sun S; Zhu J; Cui L; Zhang HL
    Mediators Inflamm; 2015; 2015():564098. PubMed ID: 26451079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immunobiology of Guillain-Barré syndromes.
    Willison HJ
    J Peripher Nerv Syst; 2005 Jun; 10(2):94-112. PubMed ID: 15958123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Axonal variants of Guillain-Barré syndrome: an update.
    Shang P; Zhu M; Wang Y; Zheng X; Wu X; Zhu J; Feng J; Zhang HL
    J Neurol; 2021 Jul; 268(7):2402-2419. PubMed ID: 32140865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bickerstaff Brainstem Encephalitis and overlapping Guillain-Barré syndrome in children: Report of two cases and review of the literature.
    Michev A; Musso P; Foiadelli T; Trabatti C; Lozza A; Franciotta D; Simoncelli AM; Savasta S
    Eur J Paediatr Neurol; 2019 Jan; 23(1):43-52. PubMed ID: 30502045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FAS promoter polymorphisms and serum sFas level are associated with increased risk of nerve damage in Bangladeshi patients with Guillain-Barré syndrome.
    Islam Z; Jahan I; Ahammad RU; Shahnaij M; Nahar S; Mohammad QD
    PLoS One; 2018; 13(2):e0192703. PubMed ID: 29432441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex differences in Guillain Barré syndrome, chronic inflammatory demyelinating polyradiculoneuropathy and experimental autoimmune neuritis.
    McCombe PA; Hardy TA; Nona RJ; Greer JM
    Front Immunol; 2022; 13():1038411. PubMed ID: 36569912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pathology of the Peripheral Nervous System in Guillain-Barré Syndrome].
    Nakano Y; Kanda T
    Brain Nerve; 2015 Nov; 67(11):1329-39. PubMed ID: 26560948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complications of Guillain-Barré syndrome.
    Wang Y; Zhang HL; Wu X; Zhu J
    Expert Rev Clin Immunol; 2016; 12(4):439-48. PubMed ID: 26642351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic basis of Guillain-Barre syndrome.
    Khanmohammadi S; Malekpour M; Jabbari P; Rezaei N
    J Neuroimmunol; 2021 Sep; 358():577651. PubMed ID: 34246981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antiganglioside antibodies--their pathophysiological effects on Guillain-Barré syndrome and variants].
    Kaida K; Kusunoki S
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(1):29-39. PubMed ID: 21372511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guillain Barré Syndrome is induced in Non-Obese Diabetic (NOD) mice following Campylobacter jejuni infection and is exacerbated by antibiotics.
    St Charles JL; Bell JA; Gadsden BJ; Malik A; Cooke H; Van de Grift LK; Kim HY; Smith EJ; Mansfield LS
    J Autoimmun; 2017 Feb; 77():11-38. PubMed ID: 27939129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies to ganglioside complexes in Guillain-Barré syndrome: clinical correlates, fine specificity and complement activation.
    Notturno F; Luciani M; Caporale CM; Ciarelli A; Uncini A
    Int J Immunopathol Pharmacol; 2009; 22(2):437-45. PubMed ID: 19505396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guillain-Barré syndrome: update on immunobiology and treatment.
    Kaida K; Kusunoki S
    Expert Rev Neurother; 2009 Sep; 9(9):1307-19. PubMed ID: 19769446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlative study between C-reactive protein, clinical severity, and nerve conduction studies in Guillain-Barrè syndrome.
    Altaweel YA; Abdelaziz S; Fathy HA; AbdelBadea S
    Egypt J Neurol Psychiatr Neurosurg; 2018; 54(1):4. PubMed ID: 29780224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guillain-Barré as an autoimmune disease.
    Shoenfeld Y; George J; Peter JB
    Int Arch Allergy Immunol; 1996 Apr; 109(4):318-26. PubMed ID: 8634515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.